Tyrosine residues of the granulocyte colony-stimulating factor receptor transmit proliferation and differentiation signals in murine bone marrow cells.

Abstract:

:Granulocyte colony-stimulating factor (G-CSF) is the major regulator of granulopoiesis and acts through binding to its specific receptor (G-CSF-R) on neutrophilic granulocytes. Previous studies of signaling from the 4 G-CSF-R cytoplasmic tyrosine residues used model cell lines that may have idiosyncratic, nonphysiological responses. This study aimed to identify specific signals transmitted by the receptor tyrosine residues in primary myeloid cells. To bypass the presence of endogenous G-CSF-R, a chimeric receptor containing the extracellular domain of the epidermal growth factor receptor in place of the entire extracellular domain of the G-CSF-R was used. A series of chimeric receptors containing tyrosine mutations to phenylalanine, either individually or collectively, was constructed and expressed in primary bone marrow cells from G-CSF-deficient mice. Proliferation and differentiation responses of receptor-expressing bone marrow cells stimulated by epidermal growth factor were measured. An increased 50% effective concentration to stimulus of the receptor Y(null) mutant indicated that specific signals from tyrosine residues were required for cell proliferation, particularly at low concentrations of stimulus. Impaired responses by mutant receptors implicated G-CSF-R Y(764) in cell proliferation and Y(729) in granulocyte differentiation signaling. In addition, different sensitivities to ligand stimulation between mutant receptors indicated that G-CSF-R Y(744) and possibly Y(729) have an inhibitory role in cell proliferation. STAT activation was not affected by tyrosine mutations, whereas ERK activation appeared to depend, at least in part, on Y(764). These observations have suggested novel roles for the G-CSF-R tyrosine residues in primary cells that were not observed previously in studies in cell lines.

journal_name

Blood

journal_title

Blood

authors

Akbarzadeh S,Ward AC,McPhee DO,Alexander WS,Lieschke GJ,Layton JE

doi

10.1182/blood.v99.3.879

subject

Has Abstract

pub_date

2002-02-01 00:00:00

pages

879-87

issue

3

eissn

0006-4971

issn

1528-0020

journal_volume

99

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Antithrombin Milano: a new variant with monomeric and dimeric inactive antithrombin III.

    abstract::A qualitative defect of antithrombin III (AT III) has been demonstrated over three generations in eight members of an Italian family by the discrepancy between a normal amount of antigen and decreased antithrombin and anti-Xa activity in the presence or in the absence of heparin. By two-dimensional immunoelectrophores...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Wolf M,Boyer C,Tripodi A,Meyer D,Larrieu MJ,Mannucci PM

    更新日期:1985-02-01 00:00:00

  • The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia.

    abstract::The level of expression of the enzyme thiopurine methyltransferase (TPMT) is an important determinant of the metabolism of thiopurines used in the treatment of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Studies in red blood cells (RBC) have shown that TPMT expression displays genetic polymorp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Coulthard SA,Howell C,Robson J,Hall AG

    更新日期:1998-10-15 00:00:00

  • Treatment of refractory adult lymphoblastic leukemia (ALL) with 4'(9-acridinylamino) methanesulfon-M-anisidide (AMSA).

    abstract::Twenty-four adults with ALL were treated with AMSA alone or in combination. Twenty-two were treated at time of relapse and two patients after failing primary induction therapy. All had been treated with anthracyclines prior to receiving AMSA. Of the 22 patients with ALL in relapse, 4 achieved a complete remission. Two...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arlin ZA,Fanucchi MP,Gee TS,Kempin SJ,Mertelsmann R,Young CW,Clarkson BD

    更新日期:1982-11-01 00:00:00

  • Marrow harvesting from normal donors.

    abstract::The experience at a single institution in harvesting marrow for allogeneic transplantation on 1,270 occasions from 1,160 normal donors is presented in detail, together with an analysis of all the donor complications. Four donors were less than 2 years old, and the youngest was 6 1/2 months. No special difficulties wer...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Buckner CD,Clift RA,Sanders JE,Stewart P,Bensinger WI,Doney KC,Sullivan KM,Witherspoon RP,Deeg HJ,Appelbaum FR

    更新日期:1984-09-01 00:00:00

  • Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.

    abstract::Mast cells are inflammatory and immunoregulatory cells resident in tissues. They develop from bone marrow-derived progenitor cells that enter the tissue through the blood circulation. The specific localization and migration of mast cells in tissues is dependent on their interaction with extracellular matrix (ECM) prot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.966

    authors: Lorentz A,Schuppan D,Gebert A,Manns MP,Bischoff SC

    更新日期:2002-02-01 00:00:00

  • Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

    abstract::Infusions of large numbers (> 10(8)/kg) of donor leukocytes can induce remissions in patients with chronic myeloid leukemia (CML) who relapse after marrow transplantation. We wanted to determine if substantially lower numbers of donor leukocytes could induce remissions and, if so, whether this would reduce the 90% inc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mackinnon S,Papadopoulos EB,Carabasi MH,Reich L,Collins NH,Boulad F,Castro-Malaspina H,Childs BH,Gillio AP,Kernan NA

    更新日期:1995-08-15 00:00:00

  • Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition.

    abstract::The interaction of menin (MEN1) and MLL (MLL1, KMT2A) is a dependency and provides a potential opportunity for treatment of NPM1-mutant (NPM1mut) and MLL-rearranged (MLL-r) leukemias. Concomitant activating driver mutations in the gene encoding the tyrosine kinase FLT3 occur in both leukemias and are particularly comm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005037

    authors: Dzama MM,Steiner M,Rausch J,Sasca D,Schönfeld J,Kunz K,Taubert MC,McGeehan GM,Chen CW,Mupo A,Hähnel P,Theobald M,Kindler T,Koche RP,Vassiliou GS,Armstrong SA,Kühn MWM

    更新日期:2020-11-19 00:00:00

  • Manipulating leukocyte interactions in vivo through optogenetic chemokine release.

    abstract::Light-mediated release of signaling ligands, such as chemoattractants, growth factors, and cytokines is an attractive strategy for investigation and therapeutic targeting of leukocyte communication and immune responses. We introduce a versatile optogenetic method to control ligand secretion, combining UV-conditioned e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-11-684852

    authors: Sarris M,Olekhnovitch R,Bousso P

    更新日期:2016-06-09 00:00:00

  • Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.

    abstract::Selinexor is the first oral selective inhibitor of nuclear export compound tested for cancer treatment. Selinexor has demonstrated a safety therapy profile with broad antitumor activity against solid and hematological malignancies in phases 2 and 3 clinical trials (#NCT03071276, #NCT02343042, #NCT02227251, #NCT0311056...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-11-752840

    authors: Machlus KR,Wu SK,Vijey P,Soussou TS,Liu ZJ,Shacham E,Unger TJ,Kashyap T,Klebanov B,Sola-Visner M,Crochiere M,Italiano JE Jr,Landesman Y

    更新日期:2017-08-31 00:00:00

  • Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2.

    abstract::Hemophagocytic lymphohistiocytosis (HLH) is an often-fatal hyperinflammatory syndrome characterized by fever, hepatosplenomegaly, cytopenia, and in some cases hemophagocytosis. Here, we describe the mutation analysis, clinical presentation, and functional analysis of natural killer (NK) cells in patients with mutation...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-282541

    authors: Meeths M,Entesarian M,Al-Herz W,Chiang SC,Wood SM,Al-Ateeqi W,Almazan F,Boelens JJ,Hasle H,Ifversen M,Lund B,van den Berg JM,Gustafsson B,Hjelmqvist H,Nordenskjöld M,Bryceson YT,Henter JI

    更新日期:2010-10-14 00:00:00

  • Human T cells expressing two additional receptors (TETARs) specific for HIV-1 recognize both epitopes.

    abstract::Adoptive TCR transfer against rapidly mutating targets, such as HIV-1 or cancer, must counteract corresponding immune escape. Hence, we generated T cells expressing two additional receptors (TETARs) specific for HIV-1 by TCR mRNA electroporation. An HLA-A2-restricted gag-specific TCR and an HLA-B13-restricted nef-spec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-347005

    authors: Hofmann C,Höfflin S,Hückelhoven A,Bergmann S,Harrer E,Schuler G,Dörrie J,Schaft N,Harrer T

    更新日期:2011-11-10 00:00:00

  • Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

    abstract::The FOXP1 forkhead transcription factor is targeted by recurrent chromosome translocations in several subtypes of B-cell non-Hodgkin lymphomas, where high-level FOXP1 protein expression has been linked to a poor prognosis. Western blotting studies of diffuse large B-cell lymphoma (DLBCL) cell lines unexpectedly identi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-09-115113

    authors: Brown PJ,Ashe SL,Leich E,Burek C,Barrans S,Fenton JA,Jack AS,Pulford K,Rosenwald A,Banham AH

    更新日期:2008-03-01 00:00:00

  • CD11/CD18-independent neutrophil adherence to laminin is mediated by the integrin VLA-6.

    abstract::Regulated adherence of polymorphonuclear leukocytes (PMNs) to endothelium and subendothelial matrix is a critical event for PMN localization at and migration into inflammatory sites. We previously reported that human PMNs stimulated in vitro adhere to laminin, the major glycoprotein of mammalian basement membrane, by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bohnsack JF

    更新日期:1992-03-15 00:00:00

  • MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML.

    abstract::The tendency of 5-methylcytosine (5mC) to undergo spontaneous deamination has had a major role in shaping the human genome, and this methylation damage remains the primary source of somatic mutations that accumulate with age. How 5mC deamination contributes to cancer risk in different tissues remains unclear. Genomic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-05-852566

    authors: Sanders MA,Chew E,Flensburg C,Zeilemaker A,Miller SE,Al Hinai AS,Bajel A,Luiken B,Rijken M,Mclennan T,Hoogenboezem RM,Kavelaars FG,Fröhling S,Blewitt ME,Bindels EM,Alexander WS,Löwenberg B,Roberts AW,Valk PJM,Majews

    更新日期:2018-10-04 00:00:00

  • Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.

    abstract::Pretreatment cytogenetics is a known predictor of outcome in hematologic malignancies. However, its usefulness in adult acute lymphoblastic leukemia (ALL) is generally limited to the presence of the Philadelphia (Ph) chromosome because of the low incidence of other recurrent abnormalities. We present centrally reviewe...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1182/blood-2006-10-051912

    authors: Moorman AV,Harrison CJ,Buck GA,Richards SM,Secker-Walker LM,Martineau M,Vance GH,Cherry AM,Higgins RR,Fielding AK,Foroni L,Paietta E,Tallman MS,Litzow MR,Wiernik PH,Rowe JM,Goldstone AH,Dewald GW,Adult Leukaemia Worki

    更新日期:2007-04-15 00:00:00

  • Dangerous small B-cell clones.

    abstract::The detection of a monoclonal immunoglobulin in serum or urine usually raises concerns about the size of the underlying B-cell-derived clone and possible systemic effects caused by its expansion. However, a small clone can synthesize a very toxic protein, producing devastating systemic damage and protean clinical pres...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2006-03-001164

    authors: Merlini G,Stone MJ

    更新日期:2006-10-15 00:00:00

  • Granulocyte-macrophage colony-stimulating factor rescues TF-1 leukemia cells from ionizing radiation-induced apoptosis through a pathway mediated by protein kinase Calpha.

    abstract::Protein kinase C (PKC) activity has a recognized role in mediating apoptosis. However, the role of individual PKC isoforms in apoptosis is poorly defined. Therefore, we investigated the translocation of individual PKC isoforms during radiation-induced apoptosis with and without rescue from apoptosis by granulocyte-mac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kelly ML,Tang Y,Rosensweig N,Clejan S,Beckman BS

    更新日期:1998-07-15 00:00:00

  • CCL16 activates an angiogenic program in vascular endothelial cells.

    abstract::Besides regulating leukocyte trafficking in normal and injured tissues, several chemokines may positively or negatively regulate angiogenesis. Here we report that CCL16 activates an angiogenic program in vascular endothelial cells by activating CCR1. CCL16 induces dose-dependent random and directional migration of end...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1387

    authors: Strasly M,Doronzo G,Cappello P,Valdembri D,Arese M,Mitola S,Moore P,Alessandri G,Giovarelli M,Bussolino F

    更新日期:2004-01-01 00:00:00

  • Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations.

    abstract::Venomous snakes produce an array of toxic compounds, including procoagulants to defend themselves and incapacitate prey. The Australian snake Pseudonaja textilis has a venom-derived prothrombin activator homologous to coagulation factors V (FV) and Xa (FXa). Here we show that the FV component (pt-FV) has unique biolog...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202663

    authors: Bos MH,Boltz M,St Pierre L,Masci PP,de Jersey J,Lavin MF,Camire RM

    更新日期:2009-07-16 00:00:00

  • SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells.

    abstract::Fanconi anemia (FA) is a hereditary disorder caused by mutations in any 1 of 22 FA genes. The disease is characterized by hypersensitivity to interstrand crosslink (ICL) inducers such as mitomycin C (MMC). In addition to promoting ICL repair, FA proteins such as RAD51, BRCA2, or FANCD2 protect stalled replication fork...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003782

    authors: Okamoto Y,Abe M,Mu A,Tempaku Y,Rogers CB,Mochizuki AL,Katsuki Y,Kanemaki MT,Takaori-Kondo A,Sobeck AT,Bielinsky AK,Takata M

    更新日期:2020-07-31 00:00:00

  • The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

    abstract::ADAMTS13 proteolytically regulates the platelet-tethering function of von Willebrand factor (VWF). ADAMTS13 function is dependent upon multiple exosites that specifically bind the unraveled VWF A2 domain and enable proteolysis. We carried out a comprehensive functional analysis of the ADAMTS13 cysteine-rich (Cys-rich)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-08-594556

    authors: de Groot R,Lane DA,Crawley JT

    更新日期:2015-03-19 00:00:00

  • Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts.

    abstract::Persistent fibrin deposition in tissues characterizes the early pathology of many types of injury. In an animal model of bleomycin-induced lung fibrosis, increased expression of type 1 plasminogen activator inhibitor (PAI-1) is associated with accumulation of fibrin in fibroproliferative lesions. Plasmin proteolysis o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hagood JS,Olman MA,Godoy JA,Rivera KE,Fuller GM

    更新日期:1996-05-01 00:00:00

  • Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.

    abstract::Positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG) was performed in non-Hodgkin's lymphoma (NHL), which is known to be highly responsive to chemotherapy, but also yields variable treatment results to answer the following questions: (1) What is the extent and time course of changes in FDG utilizatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Römer W,Hanauske AR,Ziegler S,Thödtmann R,Weber W,Fuchs C,Enne W,Herz M,Nerl C,Garbrecht M,Schwaiger M

    更新日期:1998-06-15 00:00:00

  • An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion.

    abstract::Approximately 50% of multi-transfused individuals become refractory to random donor platelets. Recent clinical data suggest that those patients receiving leukocyte-depleted blood products are less likely to become refractory to random donor platelets than recipients of non-leukocyte-depleted products. Leukocyte deplet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Blajchman MA,Bardossy L,Carmen RA,Goldman M,Heddle NM,Singal DP

    更新日期:1992-03-01 00:00:00

  • Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia.

    abstract::Folylpolyglutamate synthetase (FPGS) is responsible for the metabolism of natural folates and a broad range of folate antagonists to polyglutamate derivatives. Recent studies indicated increased accumulation of methotrexate (MTX) polyglutamates (MTX-PG) in blast cells as a predictor of favorable treatment outcome in c...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Barredo JC,Synold TW,Laver J,Relling MV,Pui CH,Priest DG,Evans WE

    更新日期:1994-07-15 00:00:00

  • Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease.

    abstract::The intestinal microbiota in allogeneic bone marrow transplant (allo-BMT) recipients modulates graft-versus-host disease (GVHD), a systemic inflammatory state initiated by donor T cells that leads to colitis, a key determinant of GVHD severity. Indole or indole derivatives produced by tryptophan metabolism in the inte...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-03-838193

    authors: Swimm A,Giver CR,DeFilipp Z,Rangaraju S,Sharma A,Ulezko Antonova A,Sonowal R,Capaldo C,Powell D,Qayed M,Kalman D,Waller EK

    更新日期:2018-12-06 00:00:00

  • A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo.

    abstract::Recently, messenger RNAs in eukaryotes have shown to associate with antisense (AS) transcript partners that are often referred to as long noncoding RNAs (lncRNAs) whose function is largely unknown. Here, we have identified a natural AS transcript for tyrosine kinase containing immunoglobulin and epidermal growth facto...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-09-242180

    authors: Li K,Blum Y,Verma A,Liu Z,Pramanik K,Leigh NR,Chun CZ,Samant GV,Zhao B,Garnaas MK,Horswill MA,Stanhope SA,North PE,Miao RQ,Wilkinson GA,Affolter M,Ramchandran R

    更新日期:2010-01-07 00:00:00

  • Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.

    abstract::Interferon (IFN) therapy has become widely used for the treatment of chronic myelogenous leukemia. Hematologic remissions can be induced in about 60% of patients. Moreover, in a small number of patients loss of the Philadelphia (Ph) chromosome and of the BCR-ABL rearrangement is observed. We have used genomic Southern...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Opalka B,Wandl UB,Becher R,Kloke O,Nagel-Hiemke M,Moritz T,Beer U,Seeber S,Niederle N

    更新日期:1991-11-01 00:00:00

  • Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988-1991).

    abstract::In The Netherlands from July 1988 to October 1991, children (0 to 16 years of age) with de novo acute lymphoblastic leukemia (ALL) were treated according to protocol ALL-7 of the Dutch Childhood Leukemia Study Group (DCLSG). In this protocol, chemotherapy and treatment stratification were identical to the ALL-BFM-86 p...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Kamps WA,Bökkerink JP,Hählen K,Hermans J,Riehm H,Gadner H,Schrappe M,Slater R,van den Berg-de Ruiter E,Smets LA,de Vaan GA,Weening RS,van Weerden JF,van Wering ER,den der Does-van den Berg A

    更新日期:1999-08-15 00:00:00

  • Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-alpha.

    abstract::A new human leukemia cell line, KT-1, was established from a patient in the blastic crisis phase of chronic myelogenous leukemia (CML). This cell line had a positive reaction for intracytoplasmic myeloperoxidase and two Philadelphia chromosomes (Ph1) [t(9;22)(q34;q11)] and lacked normal copies of chromosomes 9 and 22....

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yanagisawa K,Yamauchi H,Kaneko M,Kohno H,Hasegawa H,Fujita S

    更新日期:1998-01-15 00:00:00